Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001–2002

References

• Williams JP, Meyers JA. Immune-mediated inflammatory disorders (I.M.I.Ds): the economic and clinical costs. Am J Manag Care 2002;8:S664–81
   PubMed Web of Science ®Google Scholar
• Davidson A, Diamond B. Autoimmune diseases. N Engl J Med 2001;345:340–50
   PubMed Web of Science ®Google Scholar
• Boren E, Gershwin ME. Inflamm-aging: autoimmunity and the immune-risk phenotype. Autoimmun Rev 2004;3:401–6
   PubMed Web of Science ®Google Scholar
• Sloka S. Observations on recent studies showing increased co-occurrence of autoimmune diseases. J Autoimmun 2002;18:251–7
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Blanchard JF, Rawsthrone RN, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: A population based study. Am J Gastroenterol 2001;96:1116–22
   PubMed Web of Science ®Google Scholar
• Kaplan MJ, Ike RW. The liver is a common non-exocrine target in primary Sjögren’s syndrome: a retrospective review. BMC Gastroenterol 2002;2:21–30
   PubMedGoogle Scholar
• Cervera R, Abarca-Costalago M, Abramovicz D, et al. Lessons from the ‘Euro-lupus cohort’. Ann Med Interne 2002;153:530–6
   PubMedGoogle Scholar
• Edwards LJ, Constantinescu CS. A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler 2004;10:575–81
   PubMed Web of Science ®Google Scholar
• Simpson CR, Anderson WJ, Helms PJ, et al. Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data. Clin Exp Allergy 2002;32:37–42
   Google Scholar
• Salvarani C, Vlachonikolis IG, van der Heijde DM, et al. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 2001;36:1307–13
   Google Scholar
• Palm O, Moum B, Ongre A, et al. Prevalence of ankylosing spondylitis and other spondylarthropathies among patients with inflammatory bowel disease: A population study (the IBSEN study). J Rheumatol 2002;29:511–5
   PubMed Web of Science ®Google Scholar
• Martins NB, Peppercorn MA. Inflammatory bowel disease. Am J Manag Care 2004;10:544–52
   PubMed Web of Science ®Google Scholar
• Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev 2003;2:119–25
   PubMed Web of Science ®Google Scholar
• Langley RGB, Krueger GG, Griffiths CEM. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005;64:ii18–23
   Google Scholar
• Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64:ii14–17
   Google Scholar
• Margolis D, Bilker W, Hennessy S, et al. The risk of malignancy associated with psoriasis. Arch Dermatol 2001;137:778–83
   PubMed Web of Science ®Google Scholar
• Feltelius N, Ekbom A, Blomqvist P. Cancer incidence among patients with ankylosing spondylitis in Sweden 1965–95: a population based cohort study. Ann Rheum Dis 2003;62: 1185–8
   Google Scholar
• Lewis JD, Bilker WB, Brensinger C, et al. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 2001;121:1080–7
   PubMed Web of Science ®Google Scholar
• Cucino C, Sonnenberg A. The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn’s disease. Am J Gastroenterol 2001;96:2107–12
   PubMed Web of Science ®Google Scholar
• Zhang JMB, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280:1690–1
   PubMed Web of Science ®Google Scholar
• Woodward M. Epidemiology: study design and data analysis (1st edn). Boca Raton, Florida: Chapman and Hall, 1999. pp.113–7
   Google Scholar
• Fishman PA, Goodman MJ, Hornbrook MC, et al. Risk adjustment using automated ambulatory pharmacy data: the RxRisk model. Med Care 2003;41:84–99
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care 1998;36:8–27
   PubMed Web of Science ®Google Scholar
• Stukenborg GJ, Wagner DP, Connors AF Jr. Comparison of the performance of two comorbitity measures, with and without information from prior hospitalizations. Med Care 2001;39:727–39
   Google Scholar
• Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care 2004;42:355–60
   Google Scholar
• Parker JP, McCombs JS, Graddy EA. Can pharmacy data improve prediction of hospital outcomes? Comparisons with a diagnosis-based comorbidity measure. Med Care 2003;41:407–19
   Google Scholar
• Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001;154:854–64
   PubMed Web of Science ®Google Scholar
• Hennessy S, Bilker WB, Weber A, et al. Descriptive analyses of the integrity of a US Medicaid claims database. Pharmacoepidemiol Drug Saf 2003;12:103–11
   PubMed Web of Science ®Google Scholar
• Zhang JX, Rathouz PJ, Chin MH. Comorbidity and the concentration of healthcare expenditures in older patients with heart failure. J Am Geriatr Soc 2003;51:476–82
   Google Scholar
• Gupta G, Gelfand JM, Lewis JD. Increased risk for demyelinating disease in patients with inflammatory bowel disease. Gastroenterology 2005;129:819–26
   Google Scholar
• Peterson E, Van Vorst K, Wickstrom S, et al. In: McGlynn EA, editor. Exploring issues in manage care: six illustrative case studies. RAND Draft Report DRU-1560-HGl 1997. pp.11,16–20, Appendix 1A
   Google Scholar
• Wallace DJ, Hahn BH, editor. Dubois' Lupus Erythematosus (6th edn). Philadelphia: Lippincott, Williams and Wilkins, 2002. pp.66–7
   Google Scholar
• Newman LS, Rose CS, Maier LA. Sarcoidosis. New Engl J Med 1997;336:1224–34
   PubMed Web of Science ®Google Scholar
• Sieper J, Braun J, Rudwalait M, et al. Ankylosing spondylitis: an overview. Ann Rheum Dis 2002:61(Suppl III):iii8–18
   Google Scholar
• Mayes MD. Scleroderma epidemiology. Rheum Dis Clin North Am 2003;29:239–54
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Dombi GW, Severson RK, et al. Risk of malignancy in scleroderma. A population-based cohort study. Arthritis Rheum 2005;52:2415–24
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005;129:827–36
   Google Scholar
• Kolodner K, Lipton RB, Lafata JE, et al. Pharmacy and medical claims data identified migraine sufferers with high specificity but modest sensitivity. J Clin Epidemiol 2004;57:962–72
   PubMed Web of Science ®Google Scholar
• Kiyota Y, Schneeweiss S, Glynn RJ, et al. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 2004;148:99–104
   PubMed Web of Science ®Google Scholar
• Goff DC, Pandey DK, Chan FA, et al. Congestive heart failure in the United States: is there more than meets the I(CD Code)? The Corpus Christi heart project. Arch Intern Med 2000;160:197–202
   PubMed Web of Science ®Google Scholar
• Birnbaum HG, Cremieux PY, Greenberg PE, et al. Using health-care claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics 1999;16:1–8
   PubMed Web of Science ®Google Scholar
• Strom BL. Data validity issues in using claims data. Pharmacoepidemiol Drug Saf 2001;10:389–92
   PubMed Web of Science ®Google Scholar
• Platt R, Kleinman K, Thompson K, et al. Using automated health plan data to assess infection risk from coronary artery bypass surgery. Emerg Infect Dis 2002;8:1433–41
   PubMed Web of Science ®Google Scholar
• Hennessy S, Bilker WB, Knauss JS, et al. Comparative cardiac safety of low-dose thioridazine and low-dose haloperidol. Br J Clin Pharmacol 2004;58:81–7
   PubMed Web of Science ®Google Scholar
• Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001;27:269–81
   PubMed Web of Science ®Google Scholar
• Schultz-Larsen F, Hanifin JM. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 2002:22:1–24
   Web of Science ®Google Scholar
• Pope GC, Urato CJ, Kulas ED, et al. Prevalence, expenditures, utilization, and payment for persons with MS in insured populations. Neurology 2002;58:37–43
   PubMed Web of Science ®Google Scholar
• Coultas DB, Zumwalt RE, Black WC, et al. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994;150:967–72
   PubMed Web of Science ®Google Scholar
• Thomas E, Hay EM, Hajeer A, et al. Sjögren’s syndrome: a community-based study of the prevalence and impact. Br J Rheumatol 1998;37:1069–76
   PubMedGoogle Scholar
• Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence and environmental influences. Gastroenterology 2004;126:1504–17
   PubMed Web of Science ®Google Scholar